News

Late last month, President Donald Trump issued letters to Lilly CEO David Ricks and to the CEOs of roughly a dozen other ...
CHICAGO — New research is showing certain weight loss drugs could be linked to eye related issues. A couple studies published in the Journal of the American Medical Association looks into Ozempic, ...
Eli Lilly has signed a deal worth $1.3 billion with privately held Superluminal Medicines to discover and develop small-molecule drugs through AI to treat obesity and other cardiometabolic diseases.
Texas is seeking more than $1 million from Eli Lilly in a lawsuit accusing the drugmaker of persuading physicians to prescribe its medications, including GLP-1s such as Mounjaro and Zepbound, through ...
Manufacturing in Ireland has long helped many American drug companies pay lower taxes. But that strategy was designed for a ...
Attorney General Ken Paxton filed a lawsuit this week against Eli Lilly for allegedly bribing Texas health care providers to ...
More than 1 in 4 adults with diabetes used one of the injectable medicines that target the GLP-1 protein last year, the ...
As the Supreme Court of Georgia tests out two minutes of uninterrupted oral argument inspired by the U.S. Supreme Court's ...
Trump administration demands lower prices in the U.S., forcing the pharmaceutical company to raise them in other markets ...
Eli Lilly has hiked the price of popular weight loss injections. The pharmaceutical giant, which manufactures the active ...
Goodpath, the leading virtual provider of whole-person care for chronic conditions, today announced a pharmacy integration agreement with Gifthealth, Eli Lilly and Company's LillyDirect pharmacy ...